Immunai
Immunai is an AI-powered biotechnology platform that combines machine learning, single-cell genomics, and immunology to accelerate drug discovery, optimize clinical trials, and improve immune-based therapies for pharmaceutical research.
What is Immunai AI?
Immunai is an AI-powered research platform that uses artificial intelligence, machine learning, and single-cell multiomics to sort of decode the human immune system. In general, the company helps pharmaceutical organizations locate therapeutic targets, get cleaner clinical trial outcomes, and speed up the creation of immune-based medicines. Their own immune database, plus the computational platform, turns messy complex biological data into something actionable, so people can move faster with precision medicine and drug discovery. By combining computational biology with advanced immunology, Immunai helps researchers understand how diseases work, predict how patients will respond to treatments, and lower risks during drug development. The end result is biomedical research that feels more efficient, more scalable, and also clearly more data-driven.
Founded in 2018, Immunai has raised well over 295 million dollars in funding and employs over 110 professionals, including more than 80 PhDs. The company operates across New York, Tel Aviv, Prague, and Zurich while collaborating with more than 27 pharmaceutical and research organizations. Its proprietary AMICA immune atlas is among the world's largest immune-focused single-cell datasets, enabling AI-powered drug discovery, target identification, and clinical trial optimization for leading global biopharmaceutical companies.
- Founder Name: Noam Solomon
- Launch Date: December 2018
Use Cases
- Drug target discovery
- Clinical trial optimization
- Precision medicine research
- Biomarker discovery
- Immunotherapy development
- Cancer research
- Autoimmune disease research
- Pharmaceutical research and development
- Immune system mapping
- Drug candidate evaluation
Technology
- Artificial Intelligence
- Machine Learning
- Single-cell Genomics
- Multiomics Analysis
- Computational Biology
- Bioinformatics
- Functional Genomics
- Predictive Analytics
- Immune Cell Profiling
- Cloud-based Data Platform
Key Features
Immunai AI's key features are
- AI-Powered Drug Discovery: Uses advanced artificial intelligence to identify promising drug targets and accelerate therapeutic research.
- AMICA Immune Atlas: Features one of the world's largest single-cell immune databases for comprehensive immune system analysis.
- Single-Cell Multiomics Analysis: Integrates genomics, transcriptomics, and proteomics data to provide deeper biological insights.
- Target Identification: Helps researchers discover and validate novel therapeutic targets for immune-related diseases.
- Biomarker Discovery: Identifies predictive biomarkers to support personalized medicine and improve patient outcomes.
- Clinical Trial Optimization: Uses AI-driven immune profiling to improve patient selection, trial design, and treatment response prediction.
- Machine Learning Models: Delivers predictive analytics for disease progression, drug efficacy, and immune responses.
- Functional Genomics Platform: Validates AI-generated discoveries using experimental biological data.
- Pharmaceutical Collaboration Platform: Enables secure collaboration between biotech companies and pharmaceutical research teams.
- Precision Medicine Support: Provides actionable immune insights for developing personalized therapies.
Pricing
- Custom enterprise pricing
- Quote-based pricing
- Strategic pharmaceutical partnerships
- Research collaboration pricing
- No publicly available subscription plans
- Contact the Immunai sales team for customized pricing
Disclaimer: For the latest and most accurate pricing information, please visit the official Immunai AI website.
Who is using it?
A diverse range of users and organizations utilize Immunai AI
- Pharmaceutical companies
- Biotechnology companies
- Drug discovery teams
- Clinical research organizations
- Immunology researchers
- Academic research institutions
- Precision medicine organizations
- Healthcare innovation companies
Alternatives
Some Immunai AI alternatives are
- Insitro
- Recursion Pharmaceuticals
- BenevolentAI
- Exscientia
- Owkin
- Tempus AI
- Schrödinger
- Atomwise
- Verge Genomics
- Relay Therapeutics
Immunai Comparison with Competitors
| Tool Name | Primary Focus | AI Technology | Best For | Pricing Model |
|---|---|---|---|---|
| Immunai | Immune system drug discovery | Machine learning and multiomics | Immunology and precision medicine | Custom enterprise |
| Insitro | Drug discovery | Machine learning | Pharmaceutical research | Enterprise |
| Exscientia | AI drug design | Artificial intelligence | Drug candidate discovery | Enterprise |
| BenevolentAI | Biomedical research | Knowledge graph AI | Drug target identification | Enterprise |
| Owkin | Federated AI | Machine learning | Clinical research | Enterprise |
How Did We Rate Immunai?
- Creative Accuracy: 9.5/10
- User Experience: 8.8/10
- Tools & Capabilities: 9.7/10
- Speed & Efficiency: 9.3/10
- Creative Freedom: 8.7/10
- Trust & Transparency: 9.4/10
- Help & Community: 8.5/10
- Value for Money: 8.9/10
- Ecosystem Fit: 9.6/10
- Overall Score: 9.2/10
Conclusion
Immunai has established itself as one of the leading AI-driven biotechnology platforms, focused on decoding the immune system for the next generation of drug discovery. It leans hard on artificial intelligence along with machine learning, single-cell genomics, and a wide set of immune datasets so pharmaceutical companies can make smarter decisions all through the research and development cycle. The platform helps find new targets, identify biomarkers, and improve clinical trials, while also reducing development risks and increasing the chances of successful treatments. Even though the pricing is enterprise-oriented and not publicly disclosed (so yeah, you won’t see it listed), Immunai still brings noticeable value to large biomedical organizations that want innovative AI solutions for precision medicine, immunology, and advanced pharmaceutical research.
People are also reading
FAQ
What is Immunai?
Immunai is an AI-powered biotechnology platform that helps pharmaceutical companies accelerate drug discovery and precision medicine using immune system data.
Is Immunai free to use?
No. Immunai provides custom enterprise solutions with pricing available upon request.
Which industries use Immunai?
Biotechnology, pharmaceuticals, healthcare research, immunology, and precision medicine.
What technologies power Immunai?
Artificial intelligence, machine learning, single-cell genomics, multiomics, bioinformatics, and computational biology.
What makes Immunai unique?
Its AMICA immune atlas, AI-powered analytics, and deep expertise in immune system biology enable advanced drug discovery and clinical trial optimization.
User Reviews
No reviews yet for Immunai.
Featured Tools
Featured AI tools from TechShark
Melody Genie
MelodyGenie is an AI-powered music generator that creates original songs from simple text prompts. Users can choose styles, moods, and genres, then instantly generate melodies and full tracks, making it easy for creators, marketers, and hobbyists to produce custom music without musical expertise.
Freemium
Kimi AI
Kimi AI is an advanced AI assistant developed by Moonshot AI that helps you chat, research, write, code, and automate tasks in one place. It supports web search, file analysis, and multimodal inputs, and can even run autonomous “agent” workflows to complete complex tasks end-to-end.
Freemium
Fashion Diffusion AI
Fashion Diffusion is an AI-powered fashion design platform that helps brands and designers create clothing designs, virtual try-ons, AI models, product photos, and marketing visuals faster and cost-effectively.
Paid
Veo 4
Veo 4 AI is an AI video creation platform that generates dramatic videos from text, images, audio, and video prompts using realistic motion and synchronized sound.
Paid
Alternatives
Alternatives to Immunai
Immunai AI alternatives include Verisl, Cytora, Shift Technology, Socotra, Earnix, and Guidewire. Immunai is an AI-powered biotech company that uses artificial intelligence, multiomics, and single-cell immune data to help pharmaceutical companies discover drug targets, optimize clinical trials, and develop precision therapies. Its advanced immune intelligence platform enables faster, data-driven decisions throughout the drug development lifecycle.
4.9Cradle
Research
Cradle helps biotechnology researchers design, engineer, and optimize proteins using artificial intelligence and laboratory data. Its capabilities include protein sequence generation, multi-property optimization, candidate scoring, and experimental learning. The platform supports pharmaceutical, agricultural, and industrial biotechnology research, helping scientific teams explore promising molecules while reducing unnecessary experimental cycles and improving research workflows.
4.8Summate.it
Research
Summate.it is a web-based AI article summarizer that helps users understand lengthy online content quickly. It extracts article text and uses OpenAI to generate concise summaries highlighting essential information. Students, researchers, marketers, and professionals can use it to review online articles efficiently, save reading time, and simplify everyday information gathering.
4.9Iris.ai
Research
Iris.ai helps enterprises and research teams organize complex information, analyze scientific literature, and build AI workflows using organizational knowledge. Its solutions support document extraction, contextual search, data processing, and AI response evaluation. The platform is particularly relevant to research-intensive businesses seeking better information retrieval, reliable answers, and controlled enterprise AI applications.
4.8Lightmatter
Research
Lightmatter develops photonic computing technologies that help AI data centers connect processors and transfer information more efficiently. Its products include Passage optical interconnects, Guide light engines, and Envise photonic AI computing technology. The company aims to address bandwidth and power constraints affecting large-scale AI training, inference, and high-performance computing infrastructure.
4.8FigEditor
Research
FigEditor AI helps researchers create scientific illustrations, flowcharts, graphical abstracts, and academic diagrams from text prompts, sketches, or reference images. Its editing and vectorization features simplify visual revisions, while SVG and high-resolution PNG exports support different research workflows. It is useful for students, scientists, educators, and research professionals preparing visual materials.
4.8GoMim
Research
GoMim is an AI math solver that helps students understand mathematical concepts through step-by-step solutions. It supports typed questions, image uploads, and subjects including algebra, geometry, and calculus. With an interactive AI tutor, question history, and free and paid plans, GoMim makes homework assistance and independent study more accessible.
4.8AlphaResearch
Research
AlphaResearch helps investors, financial analysts, and corporate strategists research companies using financial documents, earnings transcripts, market data, and sentiment analysis. Its features include document search, filing alerts, stock screening, institutional ownership tracking, and research notes. The platform simplifies financial information discovery, helping users investigate companies and support informed investment research decisions.
4.8Gatsbi
Research
Gatsbi is an AI research assistant that helps researchers discover ideas, draft academic papers, review scientific literature, and prepare patent disclosures. It combines research discovery, manuscript generation, and evidence synthesis in one workflow. The tool is useful for academics, scientists, engineers, and innovation teams seeking to streamline complex research tasks.
4.9Metagene-1
Research
METAGENE-1 is a metagenomic foundation model designed to help researchers analyze DNA and RNA sequences. Trained on extensive wastewater sequencing data, it supports genomic embedding, pathogen detection research, biosurveillance, and pandemic monitoring. The model provides researchers with an AI-based approach to studying microbial diversity and identifying patterns in complex metagenomic datasets.